CJJD NASDAQ
China Jo-Jo Drugstores, Inc.
1W: +12.6%
1M: -34.8%
3M: -44.7%
1Y: -67.4%
3Y: -98.7%
5Y: -99.7%
$1.52
Last traded 2025-03-31 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
#49
of 96
Medical - Pharmaceuticals
Technical Signal Map
2 Bullish
4 Neutral
7 Bearish
CJJD
$10M
China Jo-Jo Drugstores, Inc.
N/A
0
603939.SS
$28B
Yifeng Pharmacy Chain Co., Ltd.
BULLISH
+75
603883.SS
$9.9B
LBX Pharmacy Chain Joint Stock Company
LEAN BULL
+18
603233.SS
$21B
DaShenLin Pharmaceutical Group Co., Ltd.
NEUTRAL
+8
002675.SZ
$11B
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
NEUTRAL
-5
2096.HK
$30B
Simcere Pharmaceutical Group Limited
NEUTRAL
-6
600332.SS
$33B
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
BEARISH
-40
600085.SS
$33B
Beijing Tongrentang Co., Ltd
BEARISH
-65
6618.HK
$116B
JD Health International Inc.
BEARISH
-66
002603.SZ
$26B
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
BEARISH
-74
600518.SS
$19B
Kangmei Pharmaceutical Co., Ltd.
BEARISH
-75
600211.SS
$12B
Tibet Rhodiola Pharmaceutical Holding Co. Class A
BEARISH
-91
002019.SZ
$11B
Yifan Pharmaceutical Co., Ltd.
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| CJJD China Jo-Jo Drugstores, Inc. | $10M | -0.0 | -127.7 | -49.9 | -4.4 | 40.9 | 3 | N/A | -67.4 |
| 603939.SS Yifeng Pharmacy Chain Co., Ltd. | $28B | 16.2 | 15.3 | 15.2 | 7.7 | 3.4 | 7 | BULLISH | -1.4 |
| 603883.SS LBX Pharmacy Chain Joint Stock Company | $9.9B | 22.9 | 6.3 | 6.3 | 3.3 | 1.2 | 7 | LEAN BULL | -28.6 |
| 603233.SS DaShenLin Pharmaceutical Group Co., Ltd. | $21B | 15.0 | 18.1 | 11.8 | 5.9 | 4.9 | 6 | NEUTRAL | 5.4 |
| 002675.SZ Yantai Dongcheng Pharmaceutical Group Co.,Ltd. | $11B | 52.8 | 4.5 | 6.0 | 8.8 | -5.8 | 6 | NEUTRAL | -25.0 |
| 2096.HK Simcere Pharmaceutical Group Limited | $30B | 16.0 | 29.9 | 31.9 | 18.1 | 18.2 | 6 | NEUTRAL | -8.4 |
| 600332.SS Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $33B | 12.5 | 6.7 | 5.1 | 1.7 | 2.8 | 4 | BEARISH | -25.0 |
| 600085.SS Beijing Tongrentang Co., Ltd | $33B | 33.5 | 7.2 | 18.4 | 6.9 | -14.7 | 5 | BEARISH | -34.8 |
| 6618.HK JD Health International Inc. | $116B | 15.4 | 19.2 | 40.8 | 8.4 | 32.5 | 6 | BEARISH | -43.4 |
| 002603.SZ Shijiazhuang Yiling Pharmaceutical Co., Ltd. | $26B | 18.7 | 12.6 | 15.3 | 21.3 | 32.2 | 7 | BEARISH | -2.2 |
| 600518.SS Kangmei Pharmaceutical Co., Ltd. | $19B | 582.6 | 0.4 | -2.9 | 4.3 | -6.4 | 6 | BEARISH | -35.0 |
| 600211.SS Tibet Rhodiola Pharmaceutical Holding Co. Class A | $12B | 11.9 | 24.2 | 55.7 | 37.2 | 1.5 | 3 | BEARISH | -11.7 |
| 002019.SZ Yifan Pharmaceutical Co., Ltd. | $11B | 37.8 | 3.4 | 3.1 | 8.1 | -3.8 | 4 | BEARISH | -35.9 |
| CJJD China Jo-Jo Drugstores, Inc. | $10M | -0.0 | -127.7 | -49.9 | -4.4 | 40.9 | 3 | N/A | -67.4 |
| 603939.SS Yifeng Pharmacy Chain Co., Ltd. | $28B | 16.2 | 15.3 | 15.2 | 7.7 | 3.4 | 7 | BULLISH | -1.4 |
| 603883.SS LBX Pharmacy Chain Joint Stock Company | $9.9B | 22.9 | 6.3 | 6.3 | 3.3 | 1.2 | 7 | LEAN BULL | -28.6 |
| 603233.SS DaShenLin Pharmaceutical Group Co., Ltd. | $21B | 15.0 | 18.1 | 11.8 | 5.9 | 4.9 | 6 | NEUTRAL | 5.4 |
| 002675.SZ Yantai Dongcheng Pharmaceutical Group Co.,Ltd. | $11B | 52.8 | 4.5 | 6.0 | 8.8 | -5.8 | 6 | NEUTRAL | -25.0 |
| 2096.HK Simcere Pharmaceutical Group Limited | $30B | 16.0 | 29.9 | 31.9 | 18.1 | 18.2 | 6 | NEUTRAL | -8.4 |
| 600332.SS Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $33B | 12.5 | 6.7 | 5.1 | 1.7 | 2.8 | 4 | BEARISH | -25.0 |
| 600085.SS Beijing Tongrentang Co., Ltd | $33B | 33.5 | 7.2 | 18.4 | 6.9 | -14.7 | 5 | BEARISH | -34.8 |
| 6618.HK JD Health International Inc. | $116B | 15.4 | 19.2 | 40.8 | 8.4 | 32.5 | 6 | BEARISH | -43.4 |
| 002603.SZ Shijiazhuang Yiling Pharmaceutical Co., Ltd. | $26B | 18.7 | 12.6 | 15.3 | 21.3 | 32.2 | 7 | BEARISH | -2.2 |
| 600518.SS Kangmei Pharmaceutical Co., Ltd. | $19B | 582.6 | 0.4 | -2.9 | 4.3 | -6.4 | 6 | BEARISH | -35.0 |
| 600211.SS Tibet Rhodiola Pharmaceutical Holding Co. Class A | $12B | 11.9 | 24.2 | 55.7 | 37.2 | 1.5 | 3 | BEARISH | -11.7 |
| 002019.SZ Yifan Pharmaceutical Co., Ltd. | $11B | 37.8 | 3.4 | 3.1 | 8.1 | -3.8 | 4 | BEARISH | -35.9 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
CJJD vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F